Komori
CellSource (4880) · TargetAdvanced

Increase in Partner Medical Institutions and Expansion into New Treatment Areas

First written in FY2019. 25 of 26 entries say "Advanced", first in FY2020-Q1. Latest entry: 2026-09-08.

26entries
7years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2020-Q1 – 2026-09-082020: 420202021: 420212022: 420222023: 420232024: 320242025: 120252026: 62026
Same theme, other companies
Expansion of the Partner Medical Corporation and Hospital NetworkA theme 2 companies write about · 0 as a headwind · 2 as a tailwind

0 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1AdvancedAnnual report

    「The number of partner medical institutions that had entered into contracts for contract processing services or medical institution support services increased by 81 from the end of the previous consolidated fiscal year to 2,183 at the end of the interim consolidated accounting period, continuing to expand steadily.」

    The number of partner medical institutions increased by 81 from 2,102 at the end of the previous fiscal year to 2,183.
  2. FY2025AdvancedAnnual report

    「The number of partner medical institutions that had entered into contracts for contract processing services or medical institution support services increased by 147 from the end of the previous fiscal year to 2,102 at the end of the consolidated fiscal year, expanding further.」

    The number of partner medical institutions increased by 147 from 1,955 at the end of the previous fiscal year to 2,102. The former consulting services have been renamed medical institution support services.
  3. FY2025-H1AdvancedAnnual report

    「The number of partner medical institutions that had entered into contracts for contract processing services or medical institution support services increased by 62 from the end of the previous fiscal year to 2,017 at the end of the interim consolidated accounting period, continuing to expand steadily.」

    The number of partner medical institutions increased by 62 from the end of the previous fiscal year to 2,017. The former consulting services have been renamed medical institution support services.
  4. FY2024-Q2AdvancedAnnual report

    「The number of partner medical institutions that had entered into contracts for contract processing services or consulting services increased by 116 from the end of the previous fiscal year to 1,865 at the end of the second quarter accounting period.」

    The number of partner medical institutions increased by 116 from 1,749 at the end of the previous fiscal year to 1,865.
  5. FY2024-Q1AdvancedAnnual report

    「The number of partner medical institutions with which contracts for contract processing services or consulting services had been concluded increased by 53 from the end of the previous fiscal year to 1,802 at the end of the first quarter of the current fiscal year, continuing its steady expansion.」

    The number of partner medical institutions increased by 53 from 1,749 at the end of the previous fiscal year to 1,802.
  6. FY2023AdvancedAnnual report

    「The number of partner medical institutions with which contracts for contract processing services or consulting services had been concluded increased by 371 from the end of the previous fiscal year to 1,749 at the end of the current fiscal year, continuing its steady expansion.」

    The number of partner medical institutions increased by 371 from 1,378 to 1,749, continuing its expansion.
  7. FY2023-Q3AdvancedAnnual report

    「The number of partner medical institutions with which contracts for contract processing services or consulting services had been concluded increased by 276 from the end of the previous fiscal year to 1,654 at the end of the third quarter of the current fiscal year, continuing its steady expansion.」

    The number of partner medical institutions increased by 276 from 1,378 at the end of the previous fiscal year to 1,654.
  8. FY2023-Q2AdvancedAnnual report

    「The number of partner medical institutions with which contracts for contract processing services or consulting services had been concluded increased by 179 from the end of the previous fiscal year to 1,557 at the end of the second quarter of the current fiscal year, continuing its steady expansion.」

    The number of partner medical institutions increased by 179 from the end of the previous fiscal year to 1,557.
  9. FY2023-Q1AdvancedAnnual report

    「The number of partner medical institutions with which contracts for contract processing services or consulting services had been concluded increased by 77 from the end of the previous fiscal year to 1,455 at the end of the first quarter of the current fiscal year, continuing its steady expansion.」

    The number of partner medical institutions increased by 77 from 1,378 at the end of the previous fiscal year to 1,455.
  10. FY2022AdvancedAnnual report

    「The number of partner medical institutions with which contracts for contract processing services or consulting services had been concluded increased by 350 from the end of the previous fiscal year to 1,378 at the end of the current fiscal year, continuing its steady expansion.」

    The number of partner medical institutions increased by 350 from 1,028 to 1,378, continuing its expansion.
  11. FY2022-Q3AdvancedAnnual report

    「Partner medical institutions (period-end) 910 1,028 1,109 1,204 1,301 +97」

    The number of partner medical institutions increased by 97 from 1,204 at the end of the previous quarter to 1,301, continuing its expansion.
  12. FY2022-Q2AdvancedAnnual report

    「Partner medical institutions (period-end) 767 910 1,028 1,109 1,204 +95」

    The number of partner medical institutions increased by 95 from 1,109 at the end of the previous quarter to 1,204, continuing its expansion.
  13. FY2022-Q1AdvancedAnnual report

    「Partner medical institutions (period-end) 653 767 910 1,028 1,109 +81」

    The number of partner medical institutions increased by 81 from 1,028 at the end of the previous quarter to 1,109, continuing its expansion.
  14. FY2021AdvancedAnnual report

    「The number of partner medical institutions increased by 478 from the end of the previous fiscal year to 1,028 at the end of the current fiscal year, continuing its steady growth.」

    The number of partner medical institutions increased by 478 from 550 to 1,028, exceeding 1,000.
  15. FY2021-Q3AdvancedAnnual report

    「Partner medical institutions (period-end) 468 550 653 767 910 +143」

    The number of partner medical institutions increased by 143 from 767 at the end of the previous quarter to 910, continuing to expand the partner base.
  16. FY2021-Q2AdvancedAnnual report

    「Partner medical institutions (period-end) 404 468 550 653 767 +114」

    The number of partner medical institutions increased by 114 from 653 at the end of the previous quarter to 767, continuing its expansion.
  17. FY2021-Q1AdvancedAnnual report

    「Partner medical institutions (period-end) 345 653 +308」

    The number of partner medical institutions increased by 308 from 345 in the same period of the previous year to 653, continuing its expansion.
  18. FY2020AdvancedAnnual report

    「The number of partner medical institutions with which contracts for contract processing services or consulting services had been concluded increased by 254 from the end of the previous fiscal year to 550 at the end of the current fiscal year, continuing its steady growth.」

    The number of partner medical institutions increased by 254 from 296 at the end of the previous fiscal year to 550.
  19. FY2020-Q3AdvancedAnnual report

    「The number of partner medical institutions with which contracts for contract processing services or consulting services had been concluded reached 468 at the end of the third quarter, an increase of 231 from the end of the same quarter of the previous year, continuing its steady growth. The utilization rate of contract services by partner medical institutions also continued to increase, reflecting effective treatment outcomes and other factors.」

    The number of partner medical institutions increased to 468, up 231 year on year. The increase in the utilization rate of contract services also continued.
  20. FY2020-Q2AdvancedAnnual report

    「The number of partner medical institutions with which contracts for contract processing services or consulting services had been concluded reached 404 at the end of the second quarter, an increase of 212 from the end of the same quarter of the previous year. The utilization rate of contract services by partner medical institutions also increased, reflecting effective treatment outcomes and other factors.」

    The number of partner medical institutions increased to 404, up 212 year on year. The increase in the utilization rate of contract services was also reported.
  21. FY2020-Q1AdvancedAnnual report

    「The number of partner medical institutions with which contracts for contract processing services or consulting services had been concluded reached 345 at the end of the first quarter, an increase of 184 from the end of the same quarter of the previous year, continuing its steady growth.」

    The number of partner medical institutions increased to 345, up 184 year on year. Progress in expanding partners through service contracts was demonstrated by specific figures.
  22. FY2019First statedAnnual report

    「Growth in partner medical institutions and expansion into new treatment fields in the regenerative medicine-related business」

    The company has identified expansion in both partners and treatment fields as directions for growth in its regenerative medicine-related business.
Moved together

"Revenue and Profit Growth Since Founding and Expansion of the Regenerative Medicine-Related Business" moved the same way as this thread, in the same document, in 17 of its 26 moves.

171611966★123456
  1. ★This thread
  2. 1Revenue and Profit Growth Since Founding and Expansion of the Regenerative Medicine-Related Business17×
  3. 2Improving contract processing capacity16×
  4. 3Investment in Human Capital and Strengthening Recruitment and Development11×
  5. 4Decline in Patient Visits and Contract Processing Volumes Due to COVID-199×
  6. 5Joint Research on Exosomes and Their Clinical Application and Commercialisation6×
  7. 6Incentives to Improve Business Performance through Stock Acquisition Rights for Employees and External Collaborators6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for CellSource yet. It last moved in the Earnings presentation of 2026-09-08: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Increase in Partner Medical Institutions and Expansion into New Treatment Areas | CellSource Co.,Ltd. (4880) | Komori